MENU
Home
Add Document
Sign In
Create An Account
PDF Reader
Full Text
Suggest Documents
Polypropylene mesh: evidence for lack of carcinogenicity.
Lack of carcinogenicity of tragacanth gum in B6C3F1 mice.
Lack of carcinogenicity of ferric chloride in F344 rats.
A potent new beta2-adrenoceptor blocking agent.
Effect of a beta-adrenergic blocking agent on dental anxiety.
Letter: Effect of new beta-adrenergic blocking agent.
Complication of oxprenolol treatment.
Nightmare cessation following alteration of ophthalmic administration of a cholinergic and a beta-blocking agent.
Lack of mutagenicity and putative carcinogenicity of several novel benzopyrene derivatives.
Possible immunological effect of oxprenolol.
Simplified method for the determination of oxprenolol and other beta-receptor-blocking agents in biological fluids by gas-liquid chromatography.
Modes of the Na channel blocking action of pilsicainide, a new antiarrhythmic agent, in cardiac cells.
Oculocutaneous reaction to oxprenolol.
Possible immunological effect of oxprenolol.
Carcinogenicity examination of 1-nitropyrene oxides and related chemicals: lack of their tumorigenic effects in a newborn mice assay.
Metoprolol--a new cardioselective beta-adrenoceptor blocking agent for treatment of tachyarrhythmias.
Clinical electrophysiological effects of atenolol--a new cardioselective beta-blocking agent.
Carcinogenicity of toxaphene: a review.
Sotalol, a pure beta-adrenergic blocking agent for treatment of essential hypertension and other cardiovascular diseases.
A tannin-blocking agent does not modify the preference of sheep towards tannin-containing plants.
Clinical observations on the neuromuscular blocking action of Org 9426, a new steroidal non-depolarizing agent.
Bromocriptine associated with a peripheral dopamine blocking agent in treatment of Parkinson's disease.
The effect of metoprolol --a new selective adrenergic beta1-receptor blocking agent-- in mild hypertension.
Anti-arrhythmic action of nadolol, a beta-adrenergic receptor blocking agent.
Lack of carcinogenicity of oxprenolol, a beta-adrenergic blocking agent.
Lack of carcinogenicity of oxprenolol, a beta-adrenergic blocking agent. - PDF Download Free
454KB Sizes
0 Downloads
0 Views
Download PDF
Recommend Documents
Polypropylene mesh: evidence for lack of carcinogenicity.
Lack of carcinogenicity of tragacanth gum in B6C3F1 mice.
Lack of carcinogenicity of ferric chloride in F344 rats.
A potent new beta2-adrenoceptor blocking agent.
Effect of a beta-adrenergic blocking agent on dental anxiety.
Letter: Effect of new beta-adrenergic blocking agent.
Complication of oxprenolol treatment.
Nightmare cessation following alteration of ophthalmic administration of a cholinergic and a beta-blocking agent.
Lack of mutagenicity and putative carcinogenicity of several novel benzopyrene derivatives.
Possible immunological effect of oxprenolol.
×
Sign In
Login with Facebook
Don't have an account?
Forgot Password?
×
Sign Up
By clicking register, I agree to your terms